title: Energy restriction: stepping stones towards cancer therapy.
authors.forename: Hany A
authors.initials: HA
authors.lastname: Omar
authors.forename: Lisa
authors.initials: L
authors.lastname: Berman-Booty
authors.forename: Jing-Ru
authors.initials: JR
authors.lastname: Weng
mesh_terms: D000091162:AMP-Activated Protein Kinase Kinases; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004734:Energy Metabolism / Q000187:drug effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006593:Hexokinase / Q000037:antagonists & inhibitors; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D009369:Neoplasms / Q000188:drug therapy*; D011494:Protein Kinases / Q000378:metabolism; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology; D045162:Thiazolidinediones / Q000737:chemistry / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D013267:Stilbenes; D045162:Thiazolidinediones; C089946:2,4-thiazolidinedione; D011494:Protein Kinases; D006593:Hexokinase; D000091162:AMP-Activated Protein Kinase Kinases; D000077185:Resveratrol